Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12145 | 928 | 32.5 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
258 | 3 | STROKE//INTRACEREBRAL HEMORRHAGE//CEREBRAL ISCHEMIA | 44849 |
2409 | 2 | BLOOD BRAIN BARRIER//CEREBROLYSIN//TYR MIF 1 | 4189 |
12145 | 1 | RMP 7//INTRACAROTID CHEMOTHERAPY//BLOOD TUMOR BARRIER | 928 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | RMP 7 | authKW | 323956 | 2% | 62% | 16 |
2 | INTRACAROTID CHEMOTHERAPY | authKW | 201529 | 1% | 88% | 7 |
3 | BLOOD TUMOR BARRIER | authKW | 193519 | 2% | 29% | 20 |
4 | BLOOD BRAIN BARRIER DISRUPTION | authKW | 171203 | 2% | 24% | 22 |
5 | RG2 GLIOMA | authKW | 161220 | 1% | 70% | 7 |
6 | INTRA ARTERIAL | authKW | 143673 | 3% | 14% | 31 |
7 | INTRACAROTID INFUSION | authKW | 118446 | 1% | 60% | 6 |
8 | INTRACAROTID ADMINISTRATION | authKW | 98709 | 0% | 100% | 3 |
9 | LOBRADIMIL | authKW | 98709 | 0% | 100% | 3 |
10 | OSMOTIC BBB DISRUPTION | authKW | 98709 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 8059 | 41% | 0% | 378 |
2 | Oncology | 3636 | 33% | 0% | 308 |
3 | Surgery | 804 | 17% | 0% | 162 |
4 | Neuroimaging | 752 | 4% | 0% | 34 |
5 | Neurosciences | 614 | 17% | 0% | 158 |
6 | Radiology, Nuclear Medicine & Medical Imaging | 432 | 9% | 0% | 88 |
7 | Pharmacology & Pharmacy | 143 | 10% | 0% | 91 |
8 | Anesthesiology | 119 | 2% | 0% | 23 |
9 | Ophthalmology | 93 | 3% | 0% | 31 |
10 | Pathology | 40 | 3% | 0% | 24 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROL L603 | 65806 | 0% | 100% | 2 |
2 | WEILL CORNELL BRAIN TUMOR | 43286 | 1% | 26% | 5 |
3 | BIOMED ENGN ELECT ENGN PHYS | 32903 | 0% | 100% | 1 |
4 | BIOMED ENGN ELECT ENGN PHYS MED | 32903 | 0% | 100% | 1 |
5 | CHEM THER EUT ANALYT PHARMACOL CORE | 32903 | 0% | 100% | 1 |
6 | CITIGRP BIOMED IMAGING CORE IL CBIC | 32903 | 0% | 100% | 1 |
7 | CITIGRP BIOMED IMAGING CORE IL CIBC | 32903 | 0% | 100% | 1 |
8 | CNRSUMR 7225ICM | 32903 | 0% | 100% | 1 |
9 | DIAGNOSZT ONKORADIOL INT | 32903 | 0% | 100% | 1 |
10 | FUNCT NEUROL SURG | 32903 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEURO-ONCOLOGY | 62270 | 11% | 2% | 101 |
2 | CANCER DRUG DELIVERY | 10200 | 1% | 5% | 6 |
3 | JOURNAL OF NEUROSURGERY | 8776 | 6% | 0% | 60 |
4 | SELECTIVE CANCER THERAPEUTICS | 8623 | 0% | 7% | 4 |
5 | CANCER TREATMENT REPORTS | 7866 | 2% | 1% | 23 |
6 | PROGRESS IN EXPERIMENTAL TUMOR RESEARCH | 7627 | 1% | 3% | 7 |
7 | NEUROSURGERY | 6276 | 5% | 0% | 50 |
8 | JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2439 | 2% | 0% | 20 |
9 | AMERICAN JOURNAL OF NEURORADIOLOGY | 1459 | 2% | 0% | 22 |
10 | NEUROLOGICAL RESEARCH | 1188 | 1% | 0% | 11 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RMP 7 | 323956 | 2% | 62% | 16 | Search RMP+7 | Search RMP+7 |
2 | INTRACAROTID CHEMOTHERAPY | 201529 | 1% | 88% | 7 | Search INTRACAROTID+CHEMOTHERAPY | Search INTRACAROTID+CHEMOTHERAPY |
3 | BLOOD TUMOR BARRIER | 193519 | 2% | 29% | 20 | Search BLOOD+TUMOR+BARRIER | Search BLOOD+TUMOR+BARRIER |
4 | BLOOD BRAIN BARRIER DISRUPTION | 171203 | 2% | 24% | 22 | Search BLOOD+BRAIN+BARRIER+DISRUPTION | Search BLOOD+BRAIN+BARRIER+DISRUPTION |
5 | RG2 GLIOMA | 161220 | 1% | 70% | 7 | Search RG2+GLIOMA | Search RG2+GLIOMA |
6 | INTRA ARTERIAL | 143673 | 3% | 14% | 31 | Search INTRA+ARTERIAL | Search INTRA+ARTERIAL |
7 | INTRACAROTID INFUSION | 118446 | 1% | 60% | 6 | Search INTRACAROTID+INFUSION | Search INTRACAROTID+INFUSION |
8 | INTRACAROTID ADMINISTRATION | 98709 | 0% | 100% | 3 | Search INTRACAROTID+ADMINISTRATION | Search INTRACAROTID+ADMINISTRATION |
9 | LOBRADIMIL | 98709 | 0% | 100% | 3 | Search LOBRADIMIL | Search LOBRADIMIL |
10 | OSMOTIC BBB DISRUPTION | 98709 | 0% | 100% | 3 | Search OSMOTIC+BBB+DISRUPTION | Search OSMOTIC+BBB+DISRUPTION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SU, YS , ALI, R , FEROZE, AH , LI, G , LAWTON, MT , CHOUDHRI, O , (2016) ENDOVASCULAR THERAPIES FOR MALIGNANT GLIOMAS: CHALLENGES AND THE FUTURE.JOURNAL OF CLINICAL NEUROSCIENCE. VOL. 26. ISSUE . P. 26 -32 | 37 | 57% | 2 |
2 | JOSHI, S , MEYERS, PM , ORNSTEIN, E , (2008) INTRACAROTID DELIVERY OF DRUGS - THE POTENTIAL AND THE PITFALLS.ANESTHESIOLOGY. VOL. 109. ISSUE 3. P. 543 -564 | 61 | 39% | 11 |
3 | JOSHI, S , SINGH-MOON, R , WANG, M , BRUCE, JN , BIGIO, IJ , MAYEVSKY, A , (2014) REAL-TIME HEMODYNAMIC RESPONSE AND MITOCHONDRIAL FUNCTION CHANGES WITH INTRACAROTID MANNITOL INJECTION.BRAIN RESEARCH. VOL. 1549. ISSUE . P. 42-51 | 30 | 68% | 1 |
4 | SHAPIRO, WR , GREEN, SB , BURGER, PC , SELKER, RG , VANGILDER, JC , ROBERTSON, JT , MEALEY, J , RANSOHOFF, J , MAHALEY, MS , (1992) A RANDOMIZED COMPARISON OF INTRAARTERIAL VERSUS INTRAVENOUS BCNU, WITH OR WITHOUT INTRAVENOUS 5-FLUOROURACIL, FOR NEWLY DIAGNOSED PATIENTS WITH MALIGNANT GLIOMA.JOURNAL OF NEUROSURGERY. VOL. 76. ISSUE 5. P. 772-781 | 38 | 84% | 160 |
5 | WANG, M , ETU, J , JOSHI, S , (2007) ENHANCED DISRUPTION OF THE BLOOD BRAIN BARRIER BY INTRACAROTID MANNITOL INJECTION DURING TRANSIENT CEREBRAL HYPOPERFUSION IN RABBITS.JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY. VOL. 19. ISSUE 4. P. 249-256 | 28 | 78% | 21 |
6 | BURKHARDT, JK , RIINA, HA , SHIN, BJ , MOLITERNO, JA , HOFSTETTER, CP , BOOCKVAR, JA , (2011) INTRA-ARTERIAL CHEMOTHERAPY FOR MALIGNANT GLIOMAS: A CRITICAL ANALYSIS.INTERVENTIONAL NEURORADIOLOGY. VOL. 17. ISSUE 3. P. 286-295 | 34 | 57% | 13 |
7 | RAPOPORT, SI , (2001) ADVANCES IN OSMOTIC OPENING OF THE BLOOD-BRAIN BARRIER TO ENHANCE CNS CHEMOTHERAPY.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 10. ISSUE 10. P. 1809-1818 | 39 | 62% | 55 |
8 | ELLIOTT, PJ , HAYWARD, NJ , DEAN, RL , BLUNT, DG , BARTUS, RT , (1996) INTRAVENOUS RMP-7 SELECTIVELY INCREASES UPTAKE OF CARBOPLATIN INTO RAT BRAIN TUMORS.CANCER RESEARCH. VOL. 56. ISSUE 17. P. 3998-4005 | 33 | 72% | 46 |
9 | BLANCHETTE, M , TREMBLAY, L , LEPAGE, M , FORTIN, D , (2014) IMPACT OF DRUG SIZE ON BRAIN TUMOR AND BRAIN PARENCHYMA DELIVERY AFTER A BLOOD-BRAIN BARRIER DISRUPTION.JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. VOL. 34. ISSUE 5. P. 820-826 | 23 | 62% | 5 |
10 | DOOLITTLE, ND , MINER, ME , HALL, WA , SIEGAL, T , HANSON, EJ , OSZTIE, E , MCALLISTER, LD , BUBALO, JS , KRAEMER, DF , FORTIN, D , ET AL (2000) SAFETY AND EFFICACY OF A MULTICENTER STUDY USING INTRAARTERIAL CHEMOTHERAPY IN CONJUNCTION WITH OSMOTIC OPENING OF THE BLOOD-BRAIN BARRIER FOR THE TREATMENT OF PATIENTS WITH MALIGNANT BRAIN TUMORS.CANCER. VOL. 88. ISSUE 3. P. 637-647 | 25 | 68% | 190 |
Classes with closest relation at Level 1 |